Stable enalapril maleate capsules and preparation method thereof

A technology of enalapril maleate and pulyl tablets, which is applied in the field of medicine, can solve the problems of restricting the product quality of enalapril maleate tablets, the inability to guarantee safe use and long-term storage, and the inability to solve problems , to prevent obesity and arteriosclerosis, accelerate gastrointestinal peristalsis, and improve hardness

Inactive Publication Date: 2015-12-09
CSPC OUYI PHARM CO LTD
View PDF7 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Existing enalapril maleate is mostly tablets, such as Yuedingning produced by China-US Hangzhou Merck Pharmaceutical Co., Ltd. and Yisu produced by Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd., but the following problems exist in the production of tablets: Malay Enalapril acid may undergo hydrolysis reaction due to the structure itself. Although the raw material itself is very stable, it is particularly easy to degrade in the preparation to produce two impurities, enalaprilat and enalapril diketone, indicating that the excipients in the preparation Accelerated the degradation of enalapril
But generally speaking, the effect is not satisfactory, and the problems in the production of enalapril maleate tablets still cannot be solved
According to research data, among the products on the market, the proportion of products with unqualified substances in 1 to 2 years after production can reach 70%, and the proportion of products with unqualified substances in 2 to 3 years after production is as high as nearly 90%, resulting in degradation during the shelf life Therefore, the degradation of enalapril maleate tablets is still a common problem, which restricts the quality of existing enalapril maleate tablets, and cannot guarantee safe clinical use and long-term storage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable enalapril maleate capsules and preparation method thereof
  • Stable enalapril maleate capsules and preparation method thereof
  • Stable enalapril maleate capsules and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1: prepare stable enalapril maleate tablet of the present invention

[0026] Element Prescription amount enalapril maleate 100g lactose monohydrate 450g microcrystalline cellulose 340g starch 24g Hypromellose 18g sodium alginate 22g Poloxamer 407 10g polyethylene glycol 4000 15g L-Arginine 10g

[0027] Pass each ingredient through a 100-mesh sieve for later use. First, add enalapril maleate and lactose monohydrate in equal amounts and mix evenly, then add L-arginine and mix evenly, then add hydroxypropyl methylcellulose, micro Mix crystalline cellulose, starch, and sodium alginate evenly, and finally add poloxamer 407 and polyethylene glycol 4000 for total mixing, measure the content of enalapril maleate, determine the tablet weight according to the content, and then press the tablet to obtain the product .

Embodiment 2

[0028] Embodiment 2: prepare stable enalapril maleate tablet of the present invention

[0029] Element Prescription amount enalapril maleate 95g lactose monohydrate 500g

[0030] microcrystalline cellulose 380g starch 30g Hypromellose 10g sodium alginate 15g Poloxamer 407 8g polyethylene glycol 4000 12g L-Arginine 8g

[0031]Pass each ingredient through a 100-mesh sieve for later use. First, add enalapril maleate and lactose monohydrate in equal amounts and mix evenly, then add L-arginine and mix evenly, then add hydroxypropyl methylcellulose, micro Mix crystalline cellulose, starch, and sodium alginate evenly, and finally add poloxamer 407 and polyethylene glycol 4000 for total mixing, measure the content of enalapril maleate, determine the tablet weight according to the content, and then press the tablet to obtain the product .

Embodiment 3

[0032] Embodiment 3: prepare stable enalapril maleate tablet of the present invention

[0033] Element Prescription amount enalapril maleate 90g lactose monohydrate 550g microcrystalline cellulose 400g starch 20g Hypromellose 20g sodium alginate 20g Poloxamer 407 5g polyethylene glycol 4000 10g L-Arginine 5g

[0034] Pass each ingredient through a 100-mesh sieve for later use. First, add enalapril maleate and lactose monohydrate in equal amounts and mix evenly, then add L-arginine and mix evenly, then add hydroxypropyl methylcellulose, micro Mix crystalline cellulose, starch, and sodium alginate evenly, and finally add poloxamer 407 and polyethylene glycol 4000 for total mixing, measure the content of enalapril maleate, determine the tablet weight according to the content, and then press the tablet to obtain the product .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to stable enalapril maleate capsules and a preparation method thereof, and belongs to the technical field of medicine. Enalapril maleate, lactose monohydrate, microcrystalline cellulose, startch, hydroxypropyl methyl cellulose, sodium alga acid, poloxamer 407, polyethylene glycol 4000 and L-arginine are preferably used as medical components of the stable enalapril maleate capsules, the degradation speed of the enalapril maleate is remarkably decreased through the mutual synergistic effect, the stability of the enalapril maleate capsules is greatly improved, and it is ensured that clinical medicine is safe, effective and capable of being stored for a long time.

Description

technical field [0001] The invention relates to a pharmaceutical preparation, in particular to a stable enalapril maleate tablet and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Enalapril maleate, the chemical name is N~[(S)~1~(ethoxycarbonyl)~3~phenylpropyl]~L~alanyl~L~proline maleate , the structural formula is as follows: [0003] [0004] Enalapril maleate is the second angiotensin-converting enzyme inhibitor drug to be marketed after captopril. As a prodrug, it is rapidly hydrolyzed in the liver to an active diacid metabolite after oral administration. Enalaprilat exerts its role as an angiotensin-converting enzyme inhibitor, so that angiotensin Ⅰ cannot be converted into angiotensin Ⅱ, which causes the relaxation of blood vessels throughout the body, and finally achieves the effect of lowering blood pressure, and can effectively treat For congestive heart failure, it has obvious antihypertensive effect o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/40A61K47/38A61P9/12
Inventor 郭军亮孙成勇张文静刘磊胡瑞娟
Owner CSPC OUYI PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap